ACR Appropriateness Criteria® Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

ACR Appropriateness Criteria® Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer

Published:2011-10 Issue:5 Volume:34 Page:537-544
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Decker Roy H.,Langer Corey J.,Rosenzweig Kenneth E.,Chang Joe Yujiao,Gewanter Richard M.,Ginsburg Mark E.,Kong Feng-Ming,Lally Brian E.,Videtic Gregory M.,Movsas Benjamin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference52 articles.

1. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging.;Fernando;Cancer,1990

2. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe dEtude et de Traitement des Cancers Bronchiques.;Dautzenberg;Cancer,1999

3. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988-1992.;Debevec;Lung Cancer,1996

4. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study.;Lafitte;Ann Thorac Surg,1996

5. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party.;Stephens;Br J Cancer,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of Positive Margins and Surgical Extent on Outcomes After Early-Stage Lung Cancer Resection;The Annals of Thoracic Surgery;2024-06

2. A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes;Seminars in Thoracic and Cardiovascular Surgery;2022-03

3. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer;Oncotarget;2017-05-23

4. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall;Clinical Lung Cancer;2017-03

5. Radiothérapie postopératoire des cancers bronchiques non à petites cellules : efficacité, volume cible, dose;Cancer/Radiothérapie;2016-04